These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9721849)

  • 21. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.
    Stachelek SJ; Song C; Alferiev I; Defelice S; Cui X; Connolly JM; Bianco RW; Levy RJ
    Gene Ther; 2004 Jan; 11(1):15-24. PubMed ID: 14681693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
    Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
    Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
    Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
    Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
    Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
    Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifications in adenoviral coat fiber proteins and transcriptional regulatory sequences enhance transgene expression.
    Perlman H; Liu H; Georganas C; Woods JM; Amin MA; Koch AE; Wickham T; Kovesdi I; Mano T; Walsh K; Pope RM
    J Rheumatol; 2002 Aug; 29(8):1593-600. PubMed ID: 12180715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gene transduction for experimental brain tumors using recombinant adenovirus vector].
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Ohmoto T; Yoshida Y; Hamada H
    No To Shinkei; 1998 Aug; 50(8):731-8. PubMed ID: 9757466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
    Timiryasova TM; Chen B; Fodor I
    J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector.
    Steinwaerder DS; Carlson CA; Otto DL; Li ZY; Ni S; Lieber A
    Nat Med; 2001 Feb; 7(2):240-3. PubMed ID: 11175857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
    Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.
    Brouwer E; Havenga MJ; Ophorst O; de Leeuw B; Gijsbers L; Gillissen G; Hoeben RC; ter Horst M; Nanda D; Dirven C; Avezaat CJ; Goudsmit J; Sillevis Smitt P
    Cancer Gene Ther; 2007 Feb; 14(2):211-9. PubMed ID: 17082793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue.
    Lipinski KS; Djeha AH; Ismail T; Mountain A; Young LS; Wrighton CJ
    Mol Ther; 2001 Oct; 4(4):365-71. PubMed ID: 11592840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gene therapy for cerebral tumors: use of an adenovirus in the glioma C6 rat model].
    Maron A
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):377-80. PubMed ID: 10992887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo.
    Rubinchik S; Woraratanadharm J; Yu H; Dong JY
    Gene Ther; 2005 Mar; 12(6):504-11. PubMed ID: 15660114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral delivery and tetracycline-dependent expression of IL-1beta-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells.
    Yu JS; Sena-Esteves M; Paulus W; Breakefield XO; Reeves SA
    Cancer Res; 1996 Dec; 56(23):5423-7. PubMed ID: 8968096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic adenoviral therapy for glioblastoma multiforme.
    Sonabend AM; Ulasov IV; Han Y; Lesniak MS
    Neurosurg Focus; 2006 Apr; 20(4):E19. PubMed ID: 16709024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel tetracycline-controlled transactivator-transrepressor system enables external control of oncolytic adenovirus replication.
    Fechner H; Wang X; Srour M; Siemetzki U; Seltmann H; Sutter AP; Scherübl H; Zouboulis CC; Schwaab R; Hillen W; Schultheiss HP; Poller W
    Gene Ther; 2003 Sep; 10(19):1680-90. PubMed ID: 12923567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.
    Huang D; Desbois A; Hou ST
    Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.